Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Edward Craighead

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Journal of Affective Disorders|February 15, 2020
Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypesAhmed T Ahmed, Siamak MahmoudianDehkordi, Sudeepa Bhattacharyya, et al.
Science Advances|February 11, 2021
Single-cell molecular profiling of all three components of the HPA axis reveals adrenal ABCB1 as a regulator of stress adaptationJuan Pablo Lopez, Elena Brivio, Alice Santambrogio, et al.
Nature. Mental Health|July 1, 2024
Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placeboCynthia H Y Fu, Mathilde Antoniades, Guray Erus, et al.
Communications Medicine|November 19, 2025
Neuroanatomical dimensions in major depression linked to cognition, adverse life events, self-harm, metabolomics and geneticsWenyi Xiao, Rachel D Woodham, Yuhan Cui, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2026
Age-dependent acceleration of structural brain aging in medication-free major depressive disorder linked to neuroanatomical phenotype findings from COORDINATE-MDD consortiumBhanu Sharma, Pedro L Ballester, Luciano Minuzzi, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Journal of Affective Disorders|February 15, 2020
Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypesAhmed T Ahmed, Siamak MahmoudianDehkordi, Sudeepa Bhattacharyya, et al.
Science Advances|February 11, 2021
Single-cell molecular profiling of all three components of the HPA axis reveals adrenal ABCB1 as a regulator of stress adaptationJuan Pablo Lopez, Elena Brivio, Alice Santambrogio, et al.
Nature. Mental Health|July 1, 2024
Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placeboCynthia H Y Fu, Mathilde Antoniades, Guray Erus, et al.
Communications Medicine|November 19, 2025
Neuroanatomical dimensions in major depression linked to cognition, adverse life events, self-harm, metabolomics and geneticsWenyi Xiao, Rachel D Woodham, Yuhan Cui, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2026
Age-dependent acceleration of structural brain aging in medication-free major depressive disorder linked to neuroanatomical phenotype findings from COORDINATE-MDD consortiumBhanu Sharma, Pedro L Ballester, Luciano Minuzzi, et al.
Pageof 9